In vitro activity of new rifamycins aganst rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteria

Tubercle

Volumn 68, Issue 3, 1987, Pages 177-182

  Dickinson, Jean M ^a   Mitchison, D A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RIFABUTIN; RIFAMPICIN; RIFAPENTINE;

DRUG EFFICACY; DRUG RESISTANCE; HUMAN; MYCOBACTERIUM AVIUM; MYCOBACTERIUM SCROFULACEUM; MYCOBACTERIUM TUBERCULOSIS;

ANTITUBERCULAR AGENTS; COMPARATIVE STUDY; DRUG RESISTANCE, MICROBIAL; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; RIFABUTIN; RIFAMPIN; RIFAMYCINS; SUPPORT, NON-U.S. GOV'T;

EID: 0023604457     PISSN: 00413879     EISSN: None     Source Type: Journal    
DOI: 10.1016/0041-3879(87)90053-5     Document Type: Article

References (19)

1. Biological activity of a new class of rifamycins spiro-piperidyl-rifamycins
2. LM 427, a new spiropiperidylrifamycin: in vitro and in vivo studies
3. Antibacterial activity of DL 473, a new semisynthetic rifamycin derivative
4. Activite de la rifampicine administree de maniere intermittente et de la cyclopentyl rifamycine (ou DL 473) sur la tuberculose experimentale de la souris
5. Pharmokinetics of new long-acting rifamycin-derivatives in man
6. Antitubercular activity in vitro and in vivo of new long-acting rifamycin derivatives
7. Pharmacokinetics of new long-acting rifamycin-derivatives in animals
8. Activity of CGP 29861. a new long lasting rifamycin-derivative against Mycobacterium tuberculosis in the mouse
9. Attivita delle ansamicine LM 427 e FCE 22250 su micobatteri atipici in vitro
10. FCE 22250: Abstract: A long-acting antibiotic belonging to the novel class of 3-azinomethyl rifamycins
11. In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin
12. Activity of the spiropiperidyl rifamycin LM 427 on rifampicin resistant Mycobacterium tuberculosis
13. Studies on the mechanism of action of the spiropiperidylrifamycin LM 427 on rifampicin-resistant M. tuberculosis
14. Determination of in vitro susceptibility of mycobacteria to ansamycin
15. Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in tuberculosis control programmes
16. A selective oleic acid albumin agar medium for tubercle bacilli
17. Co-operative controlled trial of a standard regimen of streptomycin PAS and isoniazid and three alternative regimens of chemotherapy in Britain
18. 3-substituted rifamycins to human and bovine albumin
19. Physiological disposition of a series of rifamycins in the rat: a comparative study